A Pan-GTPase Inhibitor as a Molecular Probe

Area of Science:

• Biochemistry and Molecular Biology
• Medicinal Chemistry
• Drug Discovery

Background:

• Overactive GTPases (guanosine triphosphateases) are implicated in various human diseases.
• Current GTPase inhibitors face limitations in clinical development.
• A need exists for novel inhibitors targeting GTPase pathways.

Purpose of the Study:

• To report the discovery of a first-in-class small molecule pan-GTPase inhibitor.
• To characterize the inhibitory activity of the compound CID1067700 against multiple GTPases.
• To identify key chemical functionalities for inhibitor development.

Main Methods:

• High-throughput screening campaign to identify potential inhibitors.
• Biochemical, cellular protein, and protein interaction assays to assess inhibition.
• Functional assays examining physiological processes regulated by GTPases.
• Structural derivatization to determine essential chemical functionalities.

Main Results:

• Discovery of CID1067700, a novel small molecule inhibitor.
• CID1067700 demonstrated inhibition of multiple GTPases across Rho, Ras, and Rab subfamilies.
• Inhibition was confirmed in biochemical, protein interaction, and cellular functional assays.
• Structure-activity relationship studies identified essential chemical features for activity.

Conclusions:

• CID1067700 is a potent pan-GTPase inhibitor.
• The compound serves as a valuable molecular probe for studying GTPase function.
• CID1067700 provides a foundation for developing novel GTPase-targeting therapeutics.